Table 4.
HR (95% CI) | Beta coefficient | P | |
---|---|---|---|
Overall | |||
Gender (women) | 0.78 (0.65–0.94) | −0.243 | 0.009 |
Age | 1.08 (1.07–1.09) | < 0.001 | 0.080 |
Previous DM | 1.63 (1.39–1.93) | 0.491 | < 0.001 |
Smoking | 1.32 (1.08–1.60) | 0.277 | 0.006 |
Previous MI | 1.53 (1.14–2.05) | 0.422 | 0.005 |
Previous CHF | 3.22 (2.45–4.23) | 1.169 | < 0.001 |
Previous PVD | 1.74 (1.18–2.57) | 0.554 | 0.005 |
Multivessel disease | 1.47 (1.21–1.78) | 0.382 | < 0.001 |
Left main disease | 1.56 (1.15–2.11) | 0.444 | 0.004 |
Stent diameter | 0.73 (0.59–0.92) | −0.308 | 0.007 |
SAP | |||
Age | 1.08 (1.06–1.10) | 0.079 | < 0.001 |
Diabetes | 1.48 (1.09–1.99) | 0.390 | 0.011 |
Previous MI | 1.94 (1.16–3.26) | 0.664 | 0.012 |
Previous CHF | 4.52 (2.88–7.08) | 1.508 | 0.000 |
Previous PVD | 2.03 (1.09–3.76) | 0.706 | 0.025 |
Multivessel disease | 1.46 (1.03–2.07) | 0.378 | 0.034 |
UAP/NSTEMI | |||
Gender (women) | 0.69 (0.53–0.89) | −0.375 | 0.005 |
Age | 1.09 (1.08–1.11) | 0.089 | < 0.001 |
Diabetes | 1.88 (1.47–2.40) | 0.630 | 0.000 |
Smoking | 1.38 (1.03–1.84) | 0.319 | 0.032 |
Previous CHF | 2.86 (1.93–4.24) | 1.052 | 0.000 |
Multivessel disease | 1.58 (1.16–2.15) | 0.457 | 0.004 |
Bifurcation | 1.37 (1.05–1.80) | 0.316 | 0.022 |
Stent diameter | 0.68 (0.49–0.95) | −0.387 | 0.023 |
Use of IVUS | 0.72 (0.54–0.95) | −0.334 | 0.018 |
STEMI | |||
Age | 1.07 (1.05–1.08) | 0.064 | < 0.001 |
Diabetes | 1.60 (1.13–2.28) | 0.472 | 0.009 |
Left main disease | 2.93 (1.49–5.77) | 1.076 | 0.002 |
No. of stents | 0.55 (0.32–0.94) | −0.603 | 0.029 |
Stent diameter | 0.62 (0.38–1.00) | −0.482 | 0.048 |
HR — hazard ratio; CI — confidence interval; SAP — stable angina pectoris; UAP — unstable angina pectoris; NSTEMI — non-ST-segment elevation MI; STEMI — ST-segment elevation MI; MI — myocardial infarction; CHF — congestive heart failure; PVD — peripheral vascular disease; IVUS — intravascular ultrasound